TCL1_NN
oncogene_NN
expression_NN
in_IN
AIDS-related_JJ
lymphomas_NNS
and_CC
lymphoid_JJ
tissues_NNS
._.

AIDS-related_JJ
non-Hodgkin_JJ
's_POS
lymphoma_NN
-LRB-_-LRB-
AIDS_NN
NHL_NN
-RRB-_-RRB-
comprises_VBZ
a_DT
diverse_JJ
and_CC
heterogeneous_JJ
group_NN
of_IN
high-grade_JJ
B_NN
cell_NN
tumors_NNS
._.

Certain_JJ
classes_NNS
of_IN
AIDS_NN
NHL_NN
are_VBP
associated_VBN
with_IN
alterations_NNS
in_IN
oncogenes_NNS
or_CC
tumor-suppressor_JJ
genes_NNS
or_CC
infections_NNS
by_IN
oncogenic_JJ
herpesviruses_NNS
._.

However_RB
,_,
the_DT
clinically_RB
significant_JJ
class_NN
of_IN
AIDS_NN
NHL_NN
designated_VBN
immunoblastic_JJ
lymphoma_NN
plasmacytoid_NN
-LRB-_-LRB-
AIDS_NN
IBLP_NN
-RRB-_-RRB-
lacks_VBZ
any_DT
consistent_JJ
genetic_JJ
alterations_NNS
._.

We_PRP
identified_VBD
the_DT
TCL1_NN
oncogene_NN
from_IN
a_DT
set_NN
of_IN
AIDS_NN
IBLP-associated_JJ
cDNA_NN
fragments_NNS
generated_VBN
by_IN
subtractive_JJ
hybridization_NN
with_IN
non-AIDS_JJ
IBLP_NN
._.

Aberrant_JJ
TCL1_NN
expression_NN
has_VBZ
been_VBN
implicated_VBN
in_IN
T_NN
cell_NN
leukemia\/lymphoma_NN
development_NN
,_,
and_CC
its_PRP$
expression_NN
also_RB
has_VBZ
been_VBN
seen_VBN
in_IN
many_JJ
established_JJ
B_NN
cell_NN
tumor_NN
lines_NNS
._.

However_RB
,_,
TCL1_NN
expression_NN
has_VBZ
not_RB
been_VBN
reported_VBN
in_IN
AIDS_NN
NHL_NN
._.

We_PRP
find_VBP
that_IN
TCL1_NN
is_VBZ
expressed_VBN
in_IN
the_DT
majority_NN
of_IN
AIDS_NN
IBLP_NN
tumors_NNS
examined_VBN
._.

TCL1_NN
protein_NN
expression_NN
is_VBZ
restricted_JJ
to_TO
tumor_NN
cells_NNS
in_IN
AIDS_NN
IBLP_NN
tissue_NN
samples_NNS
analyzed_VBN
with_IN
immunohistochemical_JJ
staining_NN
._.

Hyperplastic_JJ
lymph_NN
node_NN
and_CC
tonsil_NN
also_RB
exhibit_VBP
strong_JJ
TCL1_NN
protein_NN
expression_NN
in_IN
mantle_NN
zone_NN
B_NN
cells_NNS
and_CC
in_IN
rare_JJ
interfollicular_JJ
zone_NN
cells_NNS
,_,
whereas_IN
follicle-center_JJ
B_NN
cells_NNS
-LRB-_-LRB-
centroblasts_NNS
and_CC
centrocytes_NNS
-RRB-_-RRB-
show_VBP
weaker_JJR
expression_NN
._.

These_DT
results_NNS
establish_VBP
TCL1_NN
as_IN
the_DT
most_RBS
prevalent_JJ
of_IN
all_DT
of_IN
the_DT
surveyed_VBN
oncogenes_NNS
associated_VBN
with_IN
AIDS_NN
IBLP_NN
._.

They_PRP
also_RB
indicate_VBP
that_IN
abundant_JJ
TCL1_NN
expression_NN
in_IN
quiescent_JJ
mantle_NN
zone_NN
B_NN
cells_NNS
is_VBZ
down-regulated_VBN
in_IN
activated_VBN
germinal_JJ
center_NN
follicular_JJ
B_NN
cells_NNS
in_IN
parallel_NN
to_TO
the_DT
known_JJ
expression_NN
pattern_NN
of_IN
BCL-2_NN
._.

High-level_JJ
expression_NN
in_IN
nonproliferating_JJ
B_NN
cells_NNS
suggests_VBZ
that_IN
TCL1_NN
may_MD
function_VB
in_IN
protecting_VBG
naive_JJ
preactivated_JJ
B_NN
cells_NNS
from_IN
apoptosis_NN
._.

